Seaport Res Ptn Has Negative View of Ashland FY2027 Earnings

Ashland Inc. (NYSE:ASH) – Investment analysts at Seaport Res Ptn dropped their FY2027 earnings estimates for shares of Ashland in a research note issued to investors on Wednesday, November 5th. Seaport Res Ptn analyst M. Harrison now anticipates that the basic materials company will post earnings per share of $4.83 for the year, down from their previous forecast of $5.38. The consensus estimate for Ashland’s current full-year earnings is $4.27 per share.

Ashland (NYSE:ASH) last released its earnings results on Thursday, June 9th. The basic materials company reported $0.56 earnings per share for the quarter. Ashland had a negative net margin of 46.01% and a positive return on equity of 6.82%. The company had revenue of $509.00 million for the quarter. Ashland has set its FY 2022 guidance at EPS.

A number of other equities analysts have also issued reports on the company. Weiss Ratings restated a “sell (d)” rating on shares of Ashland in a research note on Wednesday, October 8th. UBS Group cut their price objective on Ashland from $73.00 to $64.00 and set a “buy” rating on the stock in a report on Thursday, August 7th. Wells Fargo & Company reduced their price objective on Ashland from $53.00 to $52.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 15th. Mizuho decreased their target price on Ashland from $58.00 to $54.00 and set an “outperform” rating for the company in a report on Friday, October 3rd. Finally, Morgan Stanley initiated coverage on shares of Ashland in a report on Monday, September 8th. They issued an “equal weight” rating and a $60.00 price target on the stock. Four investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $60.43.

Ashland Trading Down 0.2%

NYSE:ASH opened at $49.97 on Monday. The company has a market capitalization of $2.28 billion, a P/E ratio of -2.67, a PEG ratio of 11.41 and a beta of 0.49. The company has a current ratio of 2.68, a quick ratio of 1.33 and a debt-to-equity ratio of 0.73. Ashland has a 12 month low of $45.21 and a 12 month high of $81.75. The firm has a fifty day simple moving average of $50.19 and a 200-day simple moving average of $51.26.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. AQR Capital Management LLC raised its position in shares of Ashland by 284.3% in the second quarter. AQR Capital Management LLC now owns 3,454,646 shares of the basic materials company’s stock worth $172,318,000 after acquiring an additional 2,555,585 shares during the period. 1832 Asset Management L.P. grew its position in shares of Ashland by 48.7% during the 1st quarter. 1832 Asset Management L.P. now owns 1,228,525 shares of the basic materials company’s stock valued at $72,839,000 after acquiring an additional 402,286 shares during the period. Cooperman Leon G increased its stake in shares of Ashland by 16.6% in the 1st quarter. Cooperman Leon G now owns 1,694,151 shares of the basic materials company’s stock valued at $100,446,000 after purchasing an additional 240,686 shares in the last quarter. Ieq Capital LLC raised its holdings in Ashland by 353.0% in the 2nd quarter. Ieq Capital LLC now owns 250,085 shares of the basic materials company’s stock worth $12,574,000 after purchasing an additional 194,880 shares during the period. Finally, Edgestream Partners L.P. boosted its position in Ashland by 5,452.8% during the first quarter. Edgestream Partners L.P. now owns 175,134 shares of the basic materials company’s stock worth $10,384,000 after purchasing an additional 171,980 shares in the last quarter. 93.95% of the stock is currently owned by hedge funds and other institutional investors.

About Ashland

Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.